在患有胃肠道瘤的患者中,甲诱导心脏毒性的危险因素
Yuting Wu1, Chen Lv2, Jindong Li1
1Department of Pharmacy, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
治疗胃肠道瘤的甲可以引起心脏毒性. 关键的危险因素包括高脂血症,糖尿病,老年,使用capecitabine和联合放射治疗.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲是胃肠道 (GI) 瘤的常见化疗剂.
- 心脏毒性是甲治疗的潜在副作用之一.
- 鉴定心脏毒性风险因素对于患者管理至关重要.
研究的目的:
- 在患有胃肠道瘤的患者中研究与甲诱导的心脏毒性相关的风险因素.
- 确定预测心脏毒性的患者人口统计和临床特征.
主要方法:
- 在2018年1月至2022年4月期间,对300名胃肠道瘤患者进行甲治疗的回顾性研究.
- 收集人口统计和临床数据.
- 多变量后勤回归分析以确定心脏毒性独立风险因素.
主要成果:
- 在300名患者中,有81名患者 (27%) 经历了甲诱导的心脏毒性.
- 在患有高血压,高脂血症,糖尿病,年龄较大,卡佩奇他治疗和联合放射治疗的患者中观察到更高的心脏毒性发病率.
- 确定了独立的风险因素:卡佩奇他治疗,有过高脂血病史,有糖尿病史,年龄较大和联合放射治疗.
结论:
- 超脂血症,糖尿病,老年,卡佩奇他治疗和辅助放射治疗是甲诱导的心脏毒性在胃肠道瘤患者潜在的独立风险因素.
- 这些发现可以帮助分层患者的风险和优化治疗策略.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Other Disorders of Digestive System
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Heart Failure Drugs: Inotropic Agents
Drugs for Treatment of Ulcerative Colitis in IBD
